noun a medical condition characterized by the absence or deficiency of gamma globulins in the blood
Agammaglobulinemia is a rare genetic disorder characterized by a lack of gamma globulins in the blood, leading to a weakened immune system.
Agammaglobulinemia is caused by mutations in genes responsible for B cell development and antibody production.
Agammaglobulinemia is a primary immunodeficiency disorder that affects the production of antibodies, leaving individuals susceptible to infections.
Agammaglobulinemia is often diagnosed in infancy or early childhood, and affected children may require lifelong immunoglobulin replacement therapy.
Agammaglobulinemia increases the risk of recurrent bacterial infections, particularly in the respiratory tract.
Agammaglobulinemia is a rare genetic disorder characterized by the absence of gamma globulins in the blood, leading to a weakened immune system. It is often diagnosed and treated by immunologists and hematologists.
Agammaglobulinemia is studied by researchers in the fields of immunology and genetics to better understand the underlying causes and potential treatments for this condition.
Nurses who work with patients diagnosed with agammaglobulinemia play a crucial role in administering treatments, monitoring symptoms, and providing support to patients and their families.